Blood Donors on Medication - an Approach to Minimize Drug Burden for Recipients of Blood Products and to Limit Deferral of Donors.
BACKGROUND: Blood products derived from donors on medication can contain drugs which might pose a risk for the recipients or influence the quality of the product itself. MATERIAL AND METHODS: To judge the eligibility of blood donors on medication, 4 drug classes have been formed with respect to their pharmacological properties, and blood products have been divided in accordance with their single-donor plasma contents. RESULTS: For drugs with dose-dependent pharmacodynamics, no deferral periods are necessary for donation of blood products containing less than 50 ml single-donor plasma for application to adults. Waiting periods of t(max) + 5 t(1/2) were calculated for the other blood products. Teratogenic drugs do not require special considerations (exception: retinoids, thalidomide and lenalidomide, dutasteride or finasteride with waiting periods for all blood products). A deferral period of t(max) + 24 t(1/2) is proposed for every blood product from blood donors on genotoxic drugs. Drugs without systemic effects can be neglected. Irreversible inhibitors of platelet function cause a 10-day waiting period if production of platelet concentrates is intended. CONCLUSION: Donors on medication are allowed to donate blood for blood products containing less than 50 ml plasma of a single donor, like red blood cell concentrates, for the use in adults without deferral periods, except those taking retinoids, thalidomide, lenalidomide, dutasteride, finasteride, or genotoxic drugs.
Becker
Christian D K
CD
Institut für Pharmakologie und Toxikologie der Bundeswehr, München, Germany.
Stichtenoth
Dirk O
DO
Wichmann
Michael G
MG
Schaefer
Christof
C
Szinicz
Ladislaus
L
Vox Sang. 1982;43(3):138-41
7147856
Drugs. 1999 Jan;57(1):111-26
9951956
J Clin Pharmacol. 1998 Oct;38(10):926-30
9807973
Clin Chem. 1987 Jan;33(1):189
3802478
Eur J Clin Pharmacol. 2001 Sep;57(6-7):433-40
11699606
Am J Med. 2006 Feb;119(2):113-6
16443409
Acta Paediatr. 2006 May;95(5):600-13
16825142
Chest. 2001 Jan;119(1 Suppl):39S-63S
11157642
Lancet. 1989 Jul 8;2(8654):93-4
2567883
J Clin Pathol. 1982 Jan;35(1):59-62
7061719
Ann Allergy. 1971 Nov;29(11):598-601
5121565
Teratology. 1997 Feb;55(2):119-31
9143092
Transfusion. 2006 Aug;46(8):1402-7
16934078
Scand J Prim Health Care. 2003 Sep;21(3):153-8
14531506
Blood. 1969 May;33(5):649-61
5779153
Thromb Haemost. 2006 Jun;95(6):949-57
16732373
Vox Sang. 1980;38(5):284-7
7415074
Am J Med. 2006 Sep;119(9):719-27
16945603
Z Kinderheilkd. 1954;74(6):610-21
13227161
Transfusion. 1977 Nov-Dec;17(6):598-601
595114
Intensive Care Med. 2001 May;27(5):925-9
11430552
CMAJ. 1986 Aug 1;135(3):215-6
3730981